|
SLFN12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.120500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.470590E-01 |
| Normal-vs-Stage2 |
1.037170E-01 |
| Normal-vs-Stage3 |
2.543400E-01 |
| Normal-vs-Stage4 |
6.049600E-01 |
| Stage1-vs-Stage2 |
2.536200E-01 |
| Stage1-vs-Stage3 |
8.201200E-01 |
| Stage1-vs-Stage4 |
7.930600E-01 |
| Stage2-vs-Stage3 |
3.502400E-01 |
| Stage2-vs-Stage4 |
2.284200E-01 |
| Stage3-vs-Stage4 |
6.901400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.148030E-01 |
| Normal-vs-AfricanAmerican |
4.524400E-02 |
| Normal-vs-Asian |
3.699800E-03 |
| Caucasian-vs-AfricanAmerican |
2.903200E-01 |
| Caucasian-vs-Asian |
2.023900E-02 |
| AfricanAmerican-vs-Asian |
1.201750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.397400E-01 |
| Normal-vs-Female |
1.140890E-03 |
| Male-vs-Female |
6.457000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.498000E-01 |
| Normal-vs-Extreme_Weight |
6.304200E-01 |
| Normal-vs-Obese |
6.502100E-02 |
| Normal-vs-Extreme_Obese |
6.994000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.157400E-01 |
| Normal_Weight-vs-Obese |
3.622400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.483200E-01 |
| Extreme_Weight-vs-Obese |
1.383450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.434000E-01 |
| Obese-vs-Extreme_Obese |
2.399200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.337700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.200600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.531600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.579700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.652600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.164140E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.700200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.563300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.935200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.234000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.684610E-01 |
| Normal-VS-Type2 PRCC |
2.403800E-01 |
| Normal-VS-KIRP CIMP |
4.025800E-02 |
| Normal-VS-Unclassified PRCC |
4.657100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.693600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.348000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.311600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.479800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.066200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.544000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.222370E-01 |
| Normal-vs-N1 |
2.247400E-01 |
| Normal-vs-N2 |
4.052600E-01 |
| N0-vs-N1 |
9.615600E-01 |
| N0-vs-N2 |
9.516200E-01 |
| N1-vs-N2 |
9.667800E-01 |
|
|
